Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMP-PD study
2010-019396-29Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico G. Rodolico - San Marco
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levodopa, entacapone and pramipexole in Parkinson's disease (PD) (4 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico G. Rodolico - San Marco. Primary endpoint: Time until occurrence of dyskinesia. Started Mar 2012; status: active.
02
Drugs
levodopaentacaponepramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-019396-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019396-29.